Key Points
- EVP Myriam Curet sold 421 shares of ISRG on Feb 11 at an average price of $494.96 for $208,378, and a string of recent insider sales has reduced her stake by about 50.72%.
- Intuitive beat expectations on Jan 22 with EPS $2.53 and revenue $2.87B (revenue up 18.8% YoY), with procedure growth and da Vinci 5 adoption cited as key fundamental drivers.
- Despite strong results, the stock has fallen mid‑double digits recently amid valuation concerns and insider selling; analysts maintain a "Moderate Buy" consensus with an average price target of $617.23.
Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) EVP Myriam Curet sold 105 shares of the stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $494.65, for a total value of $51,938.25. Following the completion of the sale, the executive vice president owned 830 shares in the company, valued at approximately $410,559.50. The trade was a 11.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Myriam Curet also recently made the following trade(s):
- On Wednesday, February 11th, Myriam Curet sold 421 shares of Intuitive Surgical stock. The stock was sold at an average price of $494.96, for a total value of $208,378.16.
- On Thursday, January 29th, Myriam Curet sold 126 shares of Intuitive Surgical stock. The shares were sold at an average price of $520.02, for a total value of $65,522.52.
- On Tuesday, January 27th, Myriam Curet sold 230 shares of Intuitive Surgical stock. The stock was sold at an average price of $532.61, for a total value of $122,500.30.
- On Wednesday, December 10th, Myriam Curet sold 104 shares of Intuitive Surgical stock. The stock was sold at an average price of $559.90, for a total transaction of $58,229.60.
Intuitive Surgical Trading Up 0.2%
Shares of ISRG stock opened at $496.12 on Thursday. The company has a market cap of $176.19 billion, a P/E ratio of 62.88, a PEG ratio of 3.84 and a beta of 1.65. The firm has a fifty day moving average price of $545.21 and a 200 day moving average price of $510.52. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $609.08.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to analysts' expectations of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business's quarterly revenue was up 18.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.21 EPS. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.
Key Stories Impacting Intuitive Surgical
Here are the key news stories impacting Intuitive Surgical this week:
- Positive Sentiment: Quarterly beat and procedure momentum support fundamentals — Intuitive’s Jan. quarter topped EPS and revenue estimates and management highlighted continued adoption of the da Vinci 5 platform, reinforcing the company’s growth narrative. MarketBeat: Growth Engine
- Positive Sentiment: Analyst coverage remains mixed but contains notable buy-side views — several firms keep buy/overweight ratings and high targets (e.g., Barclays, BTIG, Leerink), supporting investor conviction that upside remains if execution continues. Globe and Mail: Analyst Insights
- Neutral Sentiment: Technical and market-data focus — traders are watching the pullback and key moving averages (50‑day vs. 200‑day) using interactive charting tools, which can amplify short‑term moves but are not fundamental drivers. Barron's Interactive Chart
- Neutral Sentiment: Short-interest figures in recent feeds appear anomalous (zeros/NaN) and likely aren’t a meaningful market driver today; treat those data points with caution.
- Negative Sentiment: Insider selling flagged — EVP Myriam Curet and VP Fredrik Widman disclosed multiple share sales in early February, with Curet reducing her holding materially; such filings often create short‑term negative sentiment. Curet SEC filing Widman SEC filing
- Negative Sentiment: Valuation questions and recent underperformance — financial press pieces are asking whether ISRG is still “priced for perfection” after a pullback, and analysts note the shares have materially underperformed the market in recent months, which may sustain near‑term caution. Yahoo Finance: Valuation Debate Zacks: Share Pullback
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on the company. Jefferies Financial Group lifted their target price on Intuitive Surgical from $550.00 to $560.00 and gave the stock a "hold" rating in a research report on Wednesday, October 22nd. Citigroup restated a "neutral" rating and set a $590.00 target price (down from $635.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Piper Sandler reiterated an "overweight" rating and issued a $620.00 price target (up previously from $610.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Robert W. Baird decreased their price target on shares of Intuitive Surgical from $655.00 to $645.00 and set an "outperform" rating for the company in a research note on Friday, January 23rd. Finally, Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $600.00 to $654.00 and gave the company an "overweight" rating in a research note on Friday, December 12th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, Intuitive Surgical has an average rating of "Moderate Buy" and an average price target of $617.23.
Check Out Our Latest Report on Intuitive Surgical
Hedge Funds Weigh In On Intuitive Surgical
Large investors have recently modified their holdings of the business. SteelPeak Wealth LLC lifted its stake in shares of Intuitive Surgical by 28.7% in the third quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider's stock valued at $18,781,000 after purchasing an additional 9,364 shares during the period. Amalgamated Bank lifted its position in shares of Intuitive Surgical by 2.2% during the 2nd quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider's stock valued at $44,311,000 after acquiring an additional 1,772 shares during the period. Atlantic Union Bankshares Corp lifted its position in shares of Intuitive Surgical by 19.3% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider's stock valued at $10,179,000 after acquiring an additional 3,676 shares during the period. Bessemer Group Inc. increased its stake in Intuitive Surgical by 89.3% in the 2nd quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider's stock valued at $428,386,000 after purchasing an additional 371,806 shares in the last quarter. Finally, World Investment Advisors raised its holdings in Intuitive Surgical by 238.3% during the third quarter. World Investment Advisors now owns 5,399 shares of the medical equipment provider's stock worth $2,415,000 after purchasing an additional 3,803 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.
Intuitive Surgical Company Profile
(
Get Free Report)
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
